Evidence map›Paper›PMID 26655874›Full record

ReviewEuropean heart journal2016

Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment.

Konstantinos C Koskinas, Giovanni J Ughi, Stephan Windecker, Guillermo J Tearney, Lorenz Räber

3 registry-linked trialsOpen access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in European heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03067844 phase3completedstarted 2017, after this paper: background citation

Effects of the PCSK9 Antibody AliroCuMab on Coronary Atherosclerosis in PatieNts With Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy And Optical Coherence Tomography Imaging Study

Ran2017Enrolled294Registered outcomes16Posted comparisons0ConditionsAtheroma; Myocardial, Coronary Circulation, Coronary VesselArmsAlirocumab
Open the trial in the graph
NCT06520904 phase4recruitingstarted 2024, after this paper: background citation

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography in Patients With Premature Coronary Artery Disease: a Randomized Controlled Trial

Ran2024Enrolled396Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease, Optical Coherence TomographyArmsPCSK9 inhibitor, Statin
Open the trial in the graph
NCT03591328 unknown statusnot on this mapstarted 2018, after this paper: background citation

Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study

Typeobservational_patient_registrySponsorSeoul National University HospitalRan2018 to 2022Enrolled429ConditionsAcute Myocardial Infarction, Unstable AnginaArmsCoronary CT angiography
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Shining light on neurovascular disease.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Konstantinos C KoskinasDepartment of Cardiology, Bern University Hospital, Bern 3010, Switzerland.
Giovanni J UghiWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Stephan WindeckerDepartment of Cardiology, Bern University Hospital, Bern 3010, Switzerland.
Guillermo J TearneyDepartment of Pathology, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA Harvard-Massachusetts Institute of Technology Health Sciences and Technology, Cambridge, MA, USA.
Lorenz RäberDepartment of Cardiology, Bern University Hospital, Bern 3010, Switzerland lorenz.raeber@insel.ch.
University Hospital of Bern · CHHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While coronary atherosclerosis is a leading cause of mortality, evaluation of coronary lesions was previously limited to either indirect angiographic assessment of the lumen silhouette or post mortem investigations. Intracoronary (IC) imaging modalities have been developed that allow for visualization and characterization of coronary atheroma in living patients. Used alone or in combination, these modalities have enhanced our understanding of pathobiological mechanisms of atherosclerosis, identified factors responsible for disease progression, and documented the ability of various medications to reverse the processes of plaque growth and destabilization. These methodologies have established a link between in vivo plaque characteristics and subsequent coronary events, thereby improving individual risk stratification, paving the way for risk-tailored systemic therapies and raising the option for pre-emptive interventions. Moreover, IC imaging is increasingly used during coronary interventions to support therapeutic decision-making in angiographically inconclusive disease, guide and optimize procedural results in selected lesion and patient subsets, and unravel mechanisms underlying stent failure. This review aims to summarize current evidence regarding the role of IC imaging for diagnosis and risk stratification of coronary atherosclerosis, and to describe its clinical role for guiding percutaneous coronary interventions. Future perspectives for in-depth plaque characterization using novel techniques and multimodality imaging approaches are also discussed.

Indexed as

Cardiac Imaging TechniquesCoronary Artery DiseaseDiagnosis, DifferentialForecastingHumansMultimodal ImagingPercutaneous Coronary InterventionPlaque, AtheroscleroticPrognosisProsthesis FailureReproducibility of ResultsStentsTomography, Optical CoherenceUltrasonography, InterventionalAtherosclerosisCoronary interventionsIntracoronary imagingVulnerable plaque

Identifiers

PMID26655874
OpenAlexW2205413694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.